Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE JOUET CHOURAQUI : revenue, balance sheet and financial ratios

PHARMACIE JOUET CHOURAQUI is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LISIEUX (14100), this company of category PME shows in 2023 a net income positive of 67 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE JOUET CHOURAQUI (SIREN 527823835)
Indicator 2023 2021 2020 2019 2017 2016 2015
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 67 328 € 316 096 € 145 696 € 78 883 € 131 529 € 148 815 € 157 935 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, PHARMACIE JOUET CHOURAQUI generates positive net income of 67 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 158 k€ -> 67 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

67 328 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

48.736%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

57.091%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

55.5%

Solvency indicators evolution
PHARMACIE JOUET CHOURAQUI

Sector positioning

Debt ratio
48.74 2023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -11 pts over 3 years

In 2023, the debt ratio of PHARMACIE JOUET CHOURAQUI (48.74) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
57.09% 2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good +10 pts over 3 years

In 2023, the financial autonomy of PHARMACIE JOUET CHOURAQUI (57.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 216.78. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

216.784

Liquidity indicators evolution
PHARMACIE JOUET CHOURAQUI

Sector positioning

Liquidity ratio
216.78 2023
2020
2021
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good +10 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE JOUET CHOURAQUI (216.78) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 236 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 888 days. Excellent situation: suppliers finance 652 days of the operating cycle (retail model).

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

236 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

888 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE JOUET CHOURAQUI

Positioning of PHARMACIE JOUET CHOURAQUI in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE JOUET CHOURAQUI is estimated at 794 435 € (range 483 134€ - 1 116 797€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
483k€ 794k€ 1116k€
794 435 € Range: 483 134€ - 1 116 797€
NAF 5 année 2023

Valuation method used

Net Income Multiple
67 328 € × 11.8x = 794 435 €
Range: 483 134€ - 1 116 798€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE JOUET CHOURAQUI with other companies in the same sector:

Frequently asked questions about PHARMACIE JOUET CHOURAQUI

What is the revenue of PHARMACIE JOUET CHOURAQUI ?

The revenue of PHARMACIE JOUET CHOURAQUI is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE JOUET CHOURAQUI profitable?

Yes, PHARMACIE JOUET CHOURAQUI generated a net profit of 67 k€ in 2023.

Where is the headquarters of PHARMACIE JOUET CHOURAQUI ?

The headquarters of PHARMACIE JOUET CHOURAQUI is located in LISIEUX (14100), in the department Calvados.

Where to find the tax return of PHARMACIE JOUET CHOURAQUI ?

The tax return of PHARMACIE JOUET CHOURAQUI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE JOUET CHOURAQUI operate?

PHARMACIE JOUET CHOURAQUI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.